M. Kulyk & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489K Buy
2,001
+92
+5% +$21.4K 0.09% 73
2025
Q4
$395K Hold
1,909
0.08% 76
2025
Q3
$354K Buy
1,909
+25
+1% +$4.28K 0.07% 75
2025
Q2
$288K Sell
1,884
-5
-0.3% -$769 0.06% 84
2025
Q1
$313K Buy
1,889
+90
+5% +$14.1K 0.07% 73
2024
Q4
$260K Sell
1,799
-2,584
-59% -$400K 0.06% 88
2024
Q3
$710K Buy
4,383
+9
+0.2% +$1.43K 0.14% 60
2024
Q2
$639K Sell
4,374
-153
-3% -$22.8K 0.15% 60
2024
Q1
$716K Buy
4,527
+1,210
+36% +$193K 0.17% 59
2023
Q4
$520K Sell
3,317
-114
-3% -$17.5K 0.12% 68
2023
Q3
$534K Sell
3,431
-110
-3% -$18.2K 0.15% 64
2023
Q2
$586K Sell
3,541
-314
-8% -$50.7K 0.16% 68
2023
Q1
$598K Sell
3,855
-150
-4% -$24.2K 0.18% 65
2022
Q4
$707K Buy
4,005
+851
+27% +$147K 0.24% 62
2022
Q3
$515K Buy
3,154
+10
+0.3% +$1.69K 0.18% 66
2022
Q2
$558K Sell
3,144
-247
-7% -$44K 0.17% 61
2022
Q1
$601K Buy
3,391
+190
+6% +$32.3K 0.16% 60
2021
Q4
$548K Sell
3,201
-86
-3% -$14.1K 0.14% 61
2021
Q3
$531K Buy
3,287
+107
+3% +$18.3K 0.17% 52
2021
Q2
$524K Sell
3,180
-581
-15% -$96.2K 0.19% 48
2021
Q1
$618K Buy
3,761
+613
+19% +$99.2K 0.23% 49
2020
Q4
$495K Buy
+3,148
New +$465K 0.27% 42

Other funds holding JNJ

M. Kulyk & Associates's JNJ Position: Q1 2026 in Review

M. Kulyk & Associates increased its Johnson & Johnson (JNJ) stake by 4.8% in Q1 2026, buying an estimated $21.4K and bringing the position to 2,001 shares worth $489K. The position accounts for 0.09% of the portfolio, ranked #73.

M. Kulyk & Associates first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. The position peaked at $716K in Q1 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • M. Kulyk & Associates held 2,001 shares of Johnson & Johnson worth $489K as of Q1 2026.
  • M. Kulyk & Associates bought 92 Johnson & Johnson shares in Q1 2026, an estimated $21.4K.
  • Johnson & Johnson made up 0.09% of M. Kulyk & Associates's portfolio in Q1 2026, its #73 holding.
  • M. Kulyk & Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • M. Kulyk & Associates's Johnson & Johnson position peaked at $716K in Q1 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on M. Kulyk & Associates's 13F filing for Q1 2026, filed 6 May 2026.